ENDRA Life Sciences (NDRA) EBT Margin (2016 - 2018)

ENDRA Life Sciences (NDRA) posted quarterly EBT Margin of 45761.31% for Q1 2018, down 36.61% quarter-over-quarter from 33498.39% in Q4 2017.

ENDRA Life Sciences (NDRA) EBT Margin (2016 - 2018) Analysis & Trends

ENDRA Life Sciences (NDRA) has reported EBT Margin for 3 consecutive years, with 45761.31% the latest figure, recorded in Q1 2018.

In Q1 2018, EBT Margin changed N/A year-over-year to 45761.31%; the TTM figure through Dec 2018 stood at 158669.6% (down 15714041.0% YoY), while the FY2018 annual figure was 158669.6%, down 15714041.0% from the prior year.
EBT Margin slipped to 45761.31% in Q1 2018 per NDRA's latest filing, from 33498.39% in the prior quarter.
Across five years, EBT Margin topped out at 133.61% in Q4 2016 and bottomed at 45761.31% in Q1 2018.
Historically, EBT Margin has averaged 16437.67% across 3 years, with a median of 2478.35% in 2017.
On a YoY basis, EBT Margin climbed as much as 3336478 bps in 2017 and fell as far as 3336478 bps in 2017.
ENDRA Life Sciences' EBT Margin stood at 133.61% in 2016, then plunged by 24971 bps to 33498.39% in 2017, then plunged by 37 bps to 45761.31% in 2018.
Business Quant data shows NDRA's EBT Margin at 45761.31% in Q1 2018, 33498.39% in Q4 2017, and 316.69% in Q3 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBT Margin (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn	16.04%
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn	17.21%
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn	-8.93%
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn	22.23%
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn	6.89%
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn	34.29%
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn	22.43%
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn	28.17%
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn	10.36%
10	ENDRA Life Sciences	7.16 Mn	1.62 Mn	-	-

Download Data